Gadolinium Deposition Seen Following Frequent Omniscan Use On MS Patients: Study

Amid continuing concerns about the potential side effects from gadolinium deposition, researchers from the University of Buffalo indicate that deposits of the toxic metal were commonly seen in brain scans of patients with multiple sclerosis who frequently received injections with the Omniscan contrast during MRI exam.

In a study published earlier this month in the medical journal Neurology, researchers indicate that data supports the growing body of evidence that that gadolinium used in MRI contrast dye may build up in the brain and body over time.

Gadolinium is a highly toxic metal contained in MRI contrast dyes, which is designed to help enhance images. However, the gadolinium is put through a chelation process, which is supposed to prevent the metal from being absorbed into the body, allowing it to pass safely with other waste products. However, in recent years several studies have found that certain types of contrast agents may leave deposits of gadolinium that build up in the body, resulting in a condition that is now increasingly referred to as gadolinium deposition disease.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

In this latest study, researchers conducted a retrospective evaluation involving 203 patients with MS and 262 age- and sex-matched controls. Mean follow-up time was 55.4 months, and the mean number of Omniscan injections was 9.2 for those who received them.

According to the findings, 49.3% of MS patients who received injections had spots of signal intensity in their magnetic resonance imaging (MRI) scans, which is a sign of gadolinium build up. None of the control subjects had signs of signal intensity in their scans.

Researchers concluded that Omniscan use in the early stages of MS is linked to a lifetime accumulation of gadolinium in the brain.

Gadolinium Injury Lawsuits

In December 2017, the FDA issued a drug safety communication for certain types of contrast agents, providing new information about the risk of gadolinium retention and potential side effects. As a result, manufacturers were required to provide new warnings and information in a Medication Guide, which all patients receiving an MRI contrast dye will be asked to read.

The FDA also recommended that health care professionals consider the fact that the body retains gadolinium when deciding whether to give it to patients that may be at higher risk of health problems. These include women who are pregnant or think they may be pregnant, patients with kidney problems, children, and patients when inflammatory conditions. The recommendations also suggest that repeated use of the contrast agents be minimized where possible, particularly when MRIs are scheduled closely together.

Patients are now urged to tell their health care professionals whether they are pregnant or may be pregnant, whether they have kidney problems, and the date of their last MRI with gadolinium, or whether they have had repeated MRI scans that involved the use of gadolinium contrast agents.

Manufacturers face a growing number of gadolinium deposition lawsuits filed in courts nationwide, and the size of the litigation is expected to continue to increase over the coming months and years.

Image Credit: |

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Gardasil Vaccine Lawsuits Being Prepared For Early Test Trials in Federal MDL
Gardasil Vaccine Lawsuits Being Prepared For Early Test Trials in Federal MDL (Posted yesterday)

In advance of a a conference this week, lawyers report that progress is being made to prepare a group of federal Gardasil vaccine lawsuits for early test trials, to help gauge how juries may respond to certain evidence and testimony that will be repeated throughout the litigation.

Enfamil Lawsuit Claims Preemie Developed NEC After Being Fed Cow's Milk-Based Infant Formula
Enfamil Lawsuit Claims Preemie Developed NEC After Being Fed Cow's Milk-Based Infant Formula (Posted 2 days ago)

Cow's milk-based infant formula products are dangerous for premature infants, according to a mother's recent Enfamil lawsuit, filed after her newborn developed necrotizing enterocolitis and suffered through surgery and continuing negative health effects.

Ozempic MDL Lawsuits Reassigned To New Judge For Further Pretrial Proceedings
Ozempic MDL Lawsuits Reassigned To New Judge For Further Pretrial Proceedings (Posted 5 days ago)

All lawsuits over Ozempic, Mounjaro, Wegovy and other GLP-1 RA drugs to U.S. District Judge Karen S. Marston, following the death last month of the judge originally appointed to preside over all claims involving stomach paralysis and other gastrointestinal injuries.